News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
840,451 Results
Type
Article (86114)
Company Profile (702)
Press Release (753635)
Section
Business (232510)
Career Advice (4123)
Deals (39702)
Drug Delivery (127)
Drug Development (90873)
Employer Resources (195)
FDA (18049)
Job Trends (17304)
News (396088)
Policy (39676)
Tag
Academia (2982)
Alliances (56716)
Alzheimer's disease (1432)
Approvals (18001)
Artificial intelligence (271)
Bankruptcy (400)
Best Places to Work (12633)
Biotechnology (481)
Breast cancer (251)
Cancer (1914)
Cardiovascular disease (154)
Career advice (3524)
CAR-T (147)
Cell therapy (427)
Clinical research (72716)
Collaboration (752)
Compensation (392)
COVID-19 (2844)
C-suite (187)
Data (1736)
Diabetes (245)
Diagnostics (6848)
Earnings (95630)
Employer resources (166)
Events (128592)
Executive appointments (622)
FDA (19050)
Funding (672)
Gene therapy (299)
GLP-1 (788)
Government (5095)
Healthcare (20852)
Infectious disease (2976)
Interviews (811)
IPO (17772)
Job creations (5183)
Job search strategy (2860)
Layoffs (524)
Legal (10089)
Lung cancer (279)
Manufacturing (280)
Medical device (14532)
Medtech (14537)
Mergers & acquisitions (22309)
Metabolic disorders (660)
Neuroscience (1910)
NextGen: Class of 2025 (7677)
Non-profit (5077)
Northern California (2234)
Obesity (363)
Opinion (264)
Patents (187)
People (64853)
Pharmaceutical (143)
Phase I (22428)
Phase II (31580)
Phase III (23779)
Pipeline (815)
Postmarket research (3552)
Preclinical (10059)
Radiopharmaceuticals (265)
Rare diseases (372)
Real estate (7382)
Regulatory (26466)
Research institute (2651)
Resumes & cover letters (649)
Southern California (1932)
Startups (4284)
United States (20571)
Vaccines (732)
Weight loss (275)
Date
Today (84)
Last 7 days (893)
Last 30 days (3053)
Last 365 days (37419)
2025 (5991)
2024 (38138)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1269)
Arizona (248)
Asia (49810)
Australia (8780)
California (5224)
Canada (1784)
China (440)
Colorado (240)
Connecticut (260)
Europe (114136)
Florida (755)
Georgia (183)
Illinois (550)
Indiana (293)
Maryland (827)
Massachusetts (4089)
Michigan (225)
Minnesota (374)
New Jersey (1479)
New York (1481)
North Carolina (1008)
Northern California (2234)
Ohio (187)
Pennsylvania (1166)
South America (1649)
Southern California (1932)
Texas (777)
Utah (162)
Washington State (522)
There are 840,451 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pain
Lexicon to Advance Non-Opioid Painkiller Despite Mid-Stage Trial Failure
Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III trials before long.
March 3, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly SAN711) Phase 1 Study
March 3, 2025
·
5 min read
Press Releases
Fresenius Continues Growth of Biosimilars Portfolio with the U.S. Availability of Otulfi® (ustekinumab-aauz)
March 3, 2025
·
13 min read
Press Releases
Edgewise Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
March 3, 2025
·
13 min read
Obesity
Obesity Late-Comer AbbVie Inks Up to $2.2B Amylin Deal With Gubra
AbbVie is joining the amylin arena, though the pharma is still far behind leaders Novo Nordisk and Eli Lilly.
March 3, 2025
·
2 min read
·
Tristan Manalac
Europe
Biogen, Eisai Continue Leqembi’s European Rally as CHMP Reaffirms Positive Opinion
Leqembi’s application now moves forward to the European Commission, which will issue a formal verdict for the injection that will apply to all EU member states as well as Norway, Liechtenstein and Iceland.
March 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival in Patients with HER2 Positive Metastatic Gastric Cancer at Interim Analysis of DESTINY-Gastric04 Phase 3 Trial
March 3, 2025
·
19 min read
Press Releases
Ameresco Announces Acquisition of ASA Controls Expanding Smart Buildings and Controls Expertise
March 3, 2025
·
2 min read
Press Releases
Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve
March 3, 2025
·
4 min read
Press Releases
Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results
March 3, 2025
·
11 min read
1 of 84,046
Next
